Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study (Q84047593)
Jump to navigation
Jump to search
scientific article published on 15 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study |
scientific article published on 15 May 2012 |
Statements
Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study (English)
Lindsay E Nicolle
G Capuano
K Ways